Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Sajjad Molavipordanjani"'
Publikováno v:
Pharmaceutical and Biomedical Research, Vol 4, Iss 3, Pp 1-8 (2018)
Quality control (QC) procedures should always be performed following radiopharmaceutical preparation and prior to patient administration. The main aim of QC is to ensure optimal radiopharmaceutical product properties except for some short half-life t
Externí odkaz:
https://doaj.org/article/0c0877d87f1f4f1db5b4845747f50a3d
Autor:
Venousheh Ranjbar, Sajjad Molavipordanjani, Javad Biabani Ardakani, Mehdi Akhlaghi, Babak Nikkholgh, Seyed Jalal Hosseinimehr
Publikováno v:
Nuclear Medicine Communications. 43:945-951
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::011021a45ad1a73093c8446747da20bb
https://doi.org/10.1097/mnm.0000000000001590
https://doi.org/10.1097/mnm.0000000000001590
Autor:
Sahar Abdi Sarkami, Sajjad Molavipordanjani, Saeed Abedian Kenari, Javad Akhtari, Pooria Gill, Hossein Ghalehnoei, Shabanali Khodashenas
Background: RNA antisense emerging as novel candidates for therapeutic purposes. As an RNA, miR-34a involves in P53 function, and triggers cancer cells apoptosis. The clinical applications of miRNAs face some limitation which can be potentially resol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32e463d6023ecb43bfbc88f5bb1bb05b
https://doi.org/10.21203/rs.3.rs-2825672/v1
https://doi.org/10.21203/rs.3.rs-2825672/v1
Autor:
Sajjad Molavipordanjani, Tahoora Mousavi, Alireza Khorramimoghaddam, Fereshteh Talebpour Amiri, Seyed Mohammad Abedi, Seyed Jalal Hosseinimehr
Publikováno v:
Annals of Nuclear Medicine.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5488f59efda2775f2ad48949b18c46b
https://doi.org/10.1007/s12149-023-01839-8
https://doi.org/10.1007/s12149-023-01839-8
Autor:
Maryam karimi, Alireza Mardanshahi, Hamid Irannejad, Seyed Mohammad Abedi, Sajjad Molavipordanjani
Publikováno v:
Bioorganic Chemistry. 135:106486
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58b61fc7b3f07f1182277d117b5854a4
https://doi.org/10.1016/j.bioorg.2023.106486
https://doi.org/10.1016/j.bioorg.2023.106486
Autor:
Seyed Mohammad Abedi, Samaneh Vaseghi, Nasrin Abbasi Gharibkandi, Alireza Mardanshahi, Sajjad Molavipordanjani
Publikováno v:
Molecular Biology Reports. 48:1-14
INTRODUCTION Radiotherapy is one of the most common types of cancer treatment modalities. Radiation can affect both cancer and normal tissues, which limits the whole delivered dose. It is well documented that radiation activates phosphatidylinositol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18fdb87979d16875fbb742eee534b74b
https://doi.org/10.1007/s11033-021-06607-3
https://doi.org/10.1007/s11033-021-06607-3
Autor:
Venousheh, Ranjbar, Sajjad, Molavipordanjani, Javad, Biabani Ardakani, Mehdi, Akhlaghi, Babak, Nikkholgh, Seyed Jalal, Hosseinimehr
Publikováno v:
Nuclear medicine communications. 43(8)
Imaging of glioblastoma multiform (GBM) tumor using 68 -Galium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraaceticacid-Ser-Ser-Ser-Leu-Thr-Val-Ser-Pro-Trp-Tyr ( 68 Ga-DOTA-(Ser)3-LTVSPWY) as a PET radiotracer for HER2 receptor due to fact that this r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3af64a8b7efa87cb8ff9ad128fbd1599
https://pubmed.ncbi.nlm.nih.gov/35754162
https://pubmed.ncbi.nlm.nih.gov/35754162
Autor:
Shahnaz Saednia, Seyed Mohammad Abedi, Saeed Emami, Seyed Jalal Hosseinimehr, Sajjad Molavipordanjani, Fereshteh Talebpour Amiri
Publikováno v:
Molecular Pharmaceutics. 18:2360-2374
With a poor prognosis, glioblastoma multiforme is the most aggressive tumor of the central nervous system in humans. The aim of this study was to develop novel tracers for the tumor targeting and imaging of overexpressed serotonin-7 receptors (5-HT7R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d48b74582c95abd4313281a229c04b64
https://doi.org/10.1021/acs.molpharmaceut.1c00172
https://doi.org/10.1021/acs.molpharmaceut.1c00172
Publikováno v:
Current Drug Metabolism. 20:1044-1052
Background: Solid Lipid Nanoparticles (SLNs) possess unique in vivo features such as high resistivity, bioavailability, and habitation at the target site. Coating nanoparticles with polymers such as chitosan greatly affects their pharmacokinetic beha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f35db4c3c96f9494441e9dd9c2793206
https://doi.org/10.2174/1389200220666191112145808
https://doi.org/10.2174/1389200220666191112145808